Evidence map›Paper›PMID 34508602›Full record

ArticleJournal of the National Cancer Institute2022

Receptivity to a Nurse-Led Symptom Management Intervention Among Highly Symptomatic Patients With Cancer.

Grant A Wintheiser, Kathryn J Ruddy, Jeph Herrin, Parvez A Rahman, Deirdre R Pachman, Aaron L Leppin, Lila J Finney Rutten, Minji K Lee, Joan M Griffin, Cindy Tofthagen and 4 more

Erratum issued Registry-linked trialAbstract read
In one paragraph

Article in Journal of the National Cancer Institute, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT03892967 (Enhanced, EHR-Facilitated Cancer Symptom Control), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03892967 nacompletednot on this map

Enhanced, EHR-Facilitated Cancer Symptom Control (E2C2) Trial

TypeinterventionalSponsorMayo ClinicRan2019 to 2023Enrolled50,207ConditionsHematopoietic and Lymphoid Cell Neoplasm, Malignant Solid NeoplasmArmsInterview, Quality-of-Life Assessment, Questionnaire Administration
3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Grant A WintheiserDepartment of Medicine, Division of Internal Medicine, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0003-4492-6342
Kathryn J RuddyDepartment of Oncology, Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA.
Jeph HerrinYale University School of Medicine, New Haven, CT, USA.ORCID 0000-0002-3671-3622
Parvez A RahmanRobert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA.
Deirdre R PachmanDivision of Palliative Medicine, Mayo Clinic, Rochester, MN, USA.
Aaron L LeppinRobert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA.
Lila J Finney RuttenRobert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA.
Minji K LeeRobert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-1301-4319
Joan M GriffinRobert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA.
Cindy TofthagenDepartment of Nursing, Nursing Research Division, Mayo Clinic, Jacksonville, FL, USA.ORCID 0000-0002-3757-5823
Linda L ChlanDepartment of Nursing, Nursing Research Division, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0001-6922-7551
Jennifer L RidgewayRobert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0001-7658-6763
Sandra A MitchellDivision of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-4153-9972
Andrea L ChevilleDepartment of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN, USA.

Funding

SIMPRO Research Center: Integration and Implementation of PROs for Symptom Management in Oncology PracticeUM1CA233080 · NCI · DANA-FARBER CANCER INST · PI HASSETT, MICHAEL JAMES, OSAROGIAGBON, RAYMOND U · 2018 to 2023
$9.1M
Enhanced, EHR-facilitated Cancer Symptom Control (E2C2) Pragmatic Clinical TrialUM1CA233033 · NCI · MAYO CLINIC ROCHESTER · PI CHEVILLE, ANDREA LYNNE · 2018 to 2018
$8.7M
Implementation and Evaluation of an Expanded Bilingual Electronic Symptom Management Program across a Multi-site, Fully-integrated Comprehensive Cancer CenterUM1CA233035 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CELLA, DAVID · 2018 to 2021
$8.1M
Coordinating Center for Research Centers for Improving Management of Symptoms During and Following Cancer TreatmentU24CA232980 · NCI · RESEARCH TRIANGLE INSTITUTE · PI ARDINI, MARY-ANNE · 2018 to 2023
$3.4M
NCI NIH HHS U24 CA232980NCI NIH HHS UM1 CA233033NCI NIH HHS UM1 CA233035NCI NIH HHS UM1 CA233080
6 · The paper itself

Abstract

backgroundThe symptom burden associated with cancer and its treatment can negatively affect patients' quality of life and survival. Symptom-focused collaborative care model (CCM) interventions can improve outcomes, but only if patients engage with them. We assessed the receptivity of severely symptomatic oncology patients to a remote nurse-led CCM intervention.

methodsIn a pragmatic, cluster-randomized, stepped-wedge trial conducted as part of the National Cancer Institute IMPACT Consortium (E2C2, NCT03892967), patients receiving cancer care were asked to rate their sleep disturbance, pain, anxiety, emotional distress, fatigue, and limitations in physical function. Patients reporting at least 1 severe symptom (≥7/10) were offered phone consultation with a nurse symptom care manager (RN SCM). Initially, patients had to "opt-in" to receive a call, but the protocol was later modified so they had to "opt-out" if they did not want a call. We assessed the impact of opt-in vs opt-out framing and patient characteristics on receptiveness to RN SCM calls. All statistical tests were 2-sided.

resultsOf the 1204 symptom assessments (from 864 patients) on which at least 1 severe symptom was documented, 469 (39.0%) indicated receptivity to an RN SCM phone call. The opt-out period (odds ratio [OR] = 1.61, 95% confidence interval [CI] = 1.12 to 2.32, P = .01), receiving care at a tertiary care center (OR = 3.59, 95% CI = 2.18 to 5.91, P < .001), and having severe pain (OR = 1.80, 95% CI = 1.24 to 2.62, P = .002) were associated with statistically significantly greater willingness to receive a call.

conclusionsMany severely symptomatic patients were not receptive to an RN SCM phone call. Better understanding of reasons for refusal and strategies for improving patient receptivity are needed.

Indexed as

NeoplasmsQuality of LifeAnxietyHumansNurse's RolePalliative Care

Identifiers

PMID34508602
PMCPMC8902324

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.